121 related articles for article (PubMed ID: 1716823)
21. Selectively enhanced sensitivity of bronchoalveolar lavage fluid (BALF) mast cells to IgE dependent stimulation in mild asthmatics.
Xie H; He S; Chen P
Asian Pac J Allergy Immunol; 2003 Jun; 21(2):83-8. PubMed ID: 14629125
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the inhibitory effect of cromoline and nedocromil Na on histamine release from airway metachromatic cells and from peripheral basophils.
Kivity S; On A; Agami O; Levo Y; Fireman E
Immunol Lett; 1996 Nov; 53(2-3):147-51. PubMed ID: 9024994
[TBL] [Abstract][Full Text] [Related]
23. Histamine secretion from human skin slices induced by anti-IgE and artificial secretagogues and the effects of sodium cromoglycate and salbutamol.
Clegg LS; Church MK; Holgate ST
Clin Allergy; 1985 Jul; 15(4):321-8. PubMed ID: 2411446
[TBL] [Abstract][Full Text] [Related]
24. Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides.
Church MK; Pao GJ; Holgate ST
J Immunol; 1982 Nov; 129(5):2116-21. PubMed ID: 6181162
[No Abstract] [Full Text] [Related]
25. A comparison of nedocromil sodium and sodium cromoglycate on human lung mast cells obtained by bronchoalveolar lavage and by dispersion of lung fragments.
Leung KB; Flint KC; Brostoff J; Hudspith BN; Johnson NM; Pearce FL
Eur J Respir Dis Suppl; 1986; 147():223-6. PubMed ID: 2429855
[TBL] [Abstract][Full Text] [Related]
26. Effect of nedocromil sodium on mediator release from mast cells.
Pearce FL
J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 2):155-8. PubMed ID: 7687609
[TBL] [Abstract][Full Text] [Related]
27. Neutrophils and mast cells: nedocromil sodium inhibits the generation of neutrophil-derived histamine-releasing activity (HRA-N).
White MV; Phillips RL; Kaliner MA
J Allergy Clin Immunol; 1991 Apr; 87(4):812-20. PubMed ID: 1707428
[TBL] [Abstract][Full Text] [Related]
28. Some characteristics of mast cells cultured from human umbilical cord blood.
Lau HY; Obata T; Nagakura T; Chow SM
Inflamm Res; 2000 Apr; 49 Suppl 1():S11-2. PubMed ID: 10864399
[No Abstract] [Full Text] [Related]
29. Cytokine release from a human mast cell line (HMC-1) in response to stimulation with anti-IgE and other secretagogues.
Wierecky J; Grabbe J; Wolff HH; Gibbs BF
Inflamm Res; 2000 Apr; 49 Suppl 1():S7-8. PubMed ID: 10864397
[No Abstract] [Full Text] [Related]
30. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.
Church MK; Hiroi J
Br J Pharmacol; 1987 Feb; 90(2):421-9. PubMed ID: 2435353
[TBL] [Abstract][Full Text] [Related]
31. Biochemical analysis of initial triggering events of IgE-mediated histamine release from human lung mast cells.
Ishizaka T; Conrad DH; Schulman ES; Sterk AR; Ishizaka K
J Immunol; 1983 May; 130(5):2357-62. PubMed ID: 6187853
[TBL] [Abstract][Full Text] [Related]
32. Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli.
Lowman MA; Rees PH; Benyon RC; Church MK
J Allergy Clin Immunol; 1988 Mar; 81(3):590-7. PubMed ID: 2450114
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of histamine release from human mast cells by natural chymase inhibitors.
He SH; Xie H; Zhang XJ; Wang XJ
Acta Pharmacol Sin; 2004 Jun; 25(6):822-6. PubMed ID: 15169639
[TBL] [Abstract][Full Text] [Related]
34. IgE-dependent activation of human lung mast cells is not associated with increased phospholipid methylation.
Benyon RC; Church MK; Holgate ST
J Immunol; 1988 Aug; 141(3):954-60. PubMed ID: 2456337
[TBL] [Abstract][Full Text] [Related]
35. Histamine release from rat neutrophils and mast cells as induced by ionophore--a pharmacological approach--.
Nagai H; Koda A
Jpn J Pharmacol; 1979 Aug; 29(4):653-9. PubMed ID: 94116
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition.
Massey WA; Cohan VL; MacGlashan DW; Gittlen SW; Kagey-Sobotka A; Lichtenstein LM; Warner JA
J Pharmacol Exp Ther; 1991 Sep; 258(3):824-9. PubMed ID: 1716311
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of histamine secretion from mast cells.
Ennis M; Truneh A; White JR; Pearce FL
Nature; 1981 Jan; 289(5794):186-7. PubMed ID: 6161310
[TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells.
Bissonnette EY; Befus AD
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):825-31. PubMed ID: 9438493
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of anti-allergic agent NCO-650 on histamine release induced by various secretagogues.
Takei M; Matumoto T; Endo K; Muramatu M
Agents Actions; 1988 Aug; 25(1-2):17-21. PubMed ID: 2461059
[TBL] [Abstract][Full Text] [Related]
40. Histamine secretion from human mesenteric and adenoidal mast cells.
Brzezińska-Błaszczyk E
Arch Immunol Ther Exp (Warsz); 1992; 40(2):97-102. PubMed ID: 1284367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
